NEJM -- Table of Contents (September 26 2002, 347 [13])

	Previous	Volume 347		September 26, 2002		Number 13	Next

Article Summaries
Summaries | PDF

Perspective: Treating Sepsis
R. P. Wenzel
Extract | Full Text | PDF

Warfarin, Aspirin, or Both after Myocardial Infarction
M. Hurlen and Others
Abstract | FREE Full Text | PDF

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
M. W. Fried and Others
Abstract | FREE Full Text | PDF

Nephrolithiasis and Osteoporosis Associated with Hypophosphatemia Caused by Mutations in the Type 2a Sodium–Phosphate Cotransporter
D. Prié and Others
Abstract | FREE Full Text | PDF

Acute Episode of Raynaud's Disease
M. J. Bluto and D. A. Norman
Extract | Full Text | PDF

An Economic Evaluation of Activated Protein C Treatment for Severe Sepsis
B. J. Manns and Others
Abstract | FREE Full Text | PDF

Raynaud's Phenomenon
F. M. Wigley
Extract | Full Text | PDF

Case 30-2002 — An Eight-Year-Old Girl with Fever, Hemoptysis, and Pulmonary Consolidations
B. P. O'Sullivan, L. A. Erickson, and J. L. Niles
Extract | Full Text | PDF

Antithrombotic Therapy after Myocardial Infarction
R. C. Becker
Extract | Full Text | PDF

NPT2a — The Key to Phosphate Homeostasis
H. M. Kronenberg
Extract | Full Text | PDF

COX Inhibitors and Thromboregulation
A. J. Marcus, M. J. Broekman, and D. J. Pinsky
Extract | Full Text | PDF

Risks and Benefits of Activated Protein C Treatment for Severe Sepsis
H. S. Warren, A. F. Suffredini, P. Q. Eichacker, and R. S. Munford
Extract | Full Text | PDF

Assessing the Use of Activated Protein C in the Treatment of Severe Sepsis
J. P. Siegel
Extract | Full Text | PDF